Clinical trial
A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention…
NCT00489151 · Hospital Authority, Hong Kong, Other · Unknown status
Key facts
| NCT number | NCT00489151 |
|---|---|
| Title | A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy |
| Official title | A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy |
| Lead sponsor | Hospital Authority, Hong Kong, Other |
| Collaborators | The University of Hong Kong |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Hepatitis B |
| Intervention type | Drug |
| Interventions | adefovir dipivoxil, lamivudine |
| Enrollment | 70 |
| Start date | Jun 1, 2005 |
| Completion | Dec 1, 2007 |
| First posted | Jun 21, 2007 |
| Last update posted | Jul 7, 2010 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: